Novel DOOR-RAME Endpoint Framework for Evaluating Antibiotic Efficacy in Clinical Trials: A Proof-of-Concept Study

Summary

This article from Open Forum Infectious Diseases (Oxford Academic) presents a proof-of-concept study applying a novel Desirability of Outcome Ranking (DOOR) endpoint that incorporates a framework for Resistance Assessment and Microbiologic Evaluation (RAME) in antibiotic clinical trials. The research aims to improve how antibiotic efficacy is evaluated by moving beyond traditional binary outcomes to a more nuanced ranking system that accounts for both clinical outcomes and antimicrobial resistance development. The study demonstrates the application of this methodology in antibiotic trial settings, offering a potential new standard for assessing treatment success that better reflects the complex trade-offs between efficacy, safety, and resistance emergence.

Source

bskyNovel DOOR-RAME Endpoint Framework for Evaluating Antibiotic Efficacy in Clinical Trials: A Proof-of-Concept Studyacademic.oup.com